← Back to Search

81mg aspirin for Postoperative Complications

N/A
Waitlist Available
Led By Joseph M Vitello, MD
Research Sponsored by Jesse Brown VA Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up intraoperative only
Awards & highlights

Study Summary

The purpose of this study is to determine whether aspirin taken in the perioperative period will increase the blood loss associated with open inguinal hernia repairs. A secondary purpose of this study is to determine if the aspirin administered in the perioperative period increases the risk of complications associated with open inguinal hernia repairs.

Eligible Conditions
  • Postoperative Complications
  • Inguinal Hernia
  • Postoperative Hemorrhage

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days post operative
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days post operative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
intraoperative blood loss
Secondary outcome measures
Number of Participants with Serious and Non-Serious Adverse Events

Trial Design

2Treatment groups
Experimental Treatment
Group I: 81mg aspirinExperimental Treatment1 Intervention
This arm will include perioperative 81 mg of aspirin.
Group II: 325mg aspirinExperimental Treatment1 Intervention
Subjects will be taking 325mg of aspirin.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Acetylsalicylic acid
FDA approved

Find a Location

Who is running the clinical trial?

Jesse Brown VA Medical CenterLead Sponsor
7 Previous Clinical Trials
1,615 Total Patients Enrolled
Joseph M Vitello, MDPrincipal InvestigatorJesse Brown VA Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~28 spots leftby Apr 2025